What are the different types of respiratory failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

RESPIRATORY FAILURE TYPES

Respiratory failure is classified into two primary physiologic types: Type 1 (acute hypoxemic respiratory failure) characterized by impaired oxygenation with PaO₂ <60 mm Hg or SpO₂ <90% on room air, and Type 2 (acute hypercapnic respiratory failure) characterized by ventilatory failure with PaCO₂ >6.1 kPa (>45 mm Hg) with accompanying respiratory acidosis (pH <7.35). 1, 2

Type 1: Acute Hypoxemic Respiratory Failure

This represents failure of oxygenation where the respiratory system cannot maintain adequate arterial oxygen levels despite the lungs' ability to eliminate CO₂.

Key Diagnostic Criteria:

  • PaO₂ <60 mm Hg (8.0 kPa) or SpO₂ <90% on room air 2, 3
  • PaO₂/FiO₂ ratio ≤300 mm Hg defines the broader spectrum 4
  • PaCO₂ is typically normal or low (due to compensatory hyperventilation)

Underlying Mechanisms:

The 2026 ATS guideline structures this around conditions causing impaired oxygenation irrespective of precipitating diagnosis 1. This includes:

  • Ventilation-perfusion (V/Q) mismatch
  • Right-to-left shunts
  • Diffusion impairment
  • Alveolar hypoventilation
  • Conditions like ARDS, pneumonia, pulmonary edema, and pulmonary embolism 2, 5

Clinical Severity Stratification:

  • Mild-moderate: SpO₂ 90-94%, requiring supplemental oxygen
  • Severe: PaO₂/FiO₂ ≤200 mm Hg with respiratory rate >25 breaths/minute or clinical signs of respiratory distress 4

Type 2: Acute Hypercapnic Respiratory Failure

This represents failure of ventilation where the respiratory system cannot maintain adequate CO₂ clearance, resulting in respiratory acidosis.

Key Diagnostic Criteria:

  • PaCO₂ >6.1 kPa (>45 mm Hg) - any value above this is abnormal 2
  • pH <7.35 indicating acute respiratory acidosis 2
  • May occur even if oxygen saturation is normal 2

Underlying Mechanisms:

The 2026 ATS guideline defines this as occurring when the respiratory system cannot meet ventilatory demand and maintain adequate CO₂ clearance 1. This reflects:

  • Reduced effective alveolar ventilation
  • Increased physiologic dead space
  • Airflow limitation and dynamic hyperinflation
  • Altered respiratory drive
  • Respiratory muscle fatigue
  • Ventilation-perfusion abnormalities increasing work of breathing 1

Common Etiologies:

  • COPD exacerbations (most common cause) 1
  • Acute asthma
  • Cardiogenic pulmonary edema
  • Obesity-related hypoventilation
  • Drug-induced hypoventilation
  • Neuromuscular disorders impairing ventilatory mechanics 1

Clinical Context:

In a hospital study of 3,524 blood gas samples, 27% showed Type 2 respiratory failure versus only 6% with Type 1, demonstrating that hypercapnia is actually more common than pure hypoxemia in hospitalized patients 2.

Important Clinical Distinctions

Acute vs. Chronic Respiratory Failure:

  • Acute: Develops rapidly over hours to days with pH <7.35
  • Acute-on-chronic: Acute decompensation in patients with baseline chronic respiratory insufficiency (e.g., COPD patients)
  • Chronic: Kidneys retain bicarbonate over days to buffer acidity, potentially normalizing pH despite elevated CO₂ 2

Mixed Respiratory Failure:

Patients can have both hypoxemia AND hypercapnia simultaneously, representing combined Type 1 and Type 2 failure. This is common in severe COPD exacerbations and advanced lung disease 1.

Critical Management Implications

The 2026 ATS guideline emphasizes that treatment approach differs fundamentally between types 1:

  • Type 1 (Hypoxemic): Focus on improving oxygenation through supplemental oxygen, HFNC, or NIV/CPAP
  • Type 2 (Hypercapnic): NIV is standard of care for COPD with acidosis, demonstrating mortality reduction; HFNC may be considered in mild-moderate hypercapnia 1

Common Pitfall:

Avoid excessive oxygen supplementation in Type 2 respiratory failure, particularly in COPD patients, as this can worsen hypercapnia by reducing hypoxic respiratory drive and worsening V/Q matching. Target SpO₂ 88-92% in these patients rather than normal ranges 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.